Oxcarbazepine versus phenytoin monotherapy for epilepsy

Cochrane Database of Systematic Reviews

Volumn , Issue 4, 2009, Pages

  Muller, Martie ^a   Marson, Anthony G ^b   Williamson, Paula R ^c  

^a Institute for Maritime Technology   (South Africa)

^b Departments of Neurology   (United Kingdom)

^c UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Anticonvulsants *therapeutic use ; Carbamazepine *analogs derivatives; therapeutic use ; Epilepsies, partial drug therapy ; Epilepsy *drug therapy ; Humans; Phenytoin *therapeutic use ; Randomized controlled trials as topic; Remission induction

Indexed keywords

OXCARBAZEPINE; PHENYTOIN; VALPROIC ACID;

ACNE; AGE DISTRIBUTION; CLINICAL TRIAL; CONGENITAL DISORDER; CONTROLLED CLINICAL TRIAL; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG TOLERABILITY; DRUG WITHDRAWAL; EPILEPSY; FOCAL EPILEPSY; GINGIVA HYPERPLASIA; GRAND MAL SEIZURE; HAZARD RATIO; HUMAN; RANDOMIZED CONTROLLED TRIAL; RASH; REMISSION; REVIEW; SEIZURE; SYSTEMATIC REVIEW; UNSPECIFIED SIDE EFFECT;

EID: 77950131639     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD003615.pub2.     Document Type: Review

References (20)

1. Bill 1997 {published data only} * Bill PA, Vigonius U, Pohlmann H, Guerreiro CAM, Kochen S, Saffer D, et al.A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in adults with previously untreated epilepsy. Epilepsy Research 1997;27(3):195- 204.
2. Guerreiro 1997 {published data only} * Guerreiro MM, Vigonius U, Pohlmann H, De Manreza ML, Fejerman N, Antoniuk SA, et al.A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in children and adolescents with epilepsy. Epilepsy Research 1997;27(2):205-13.
3. Christe 1997 {published data only} * Christe W, Kramer G, Vigonius U, Pohlmann H, Steinhoff BJ, Brodie MJ, et al.A double-blind controlled clinical trial: oxcarbazepine versus sodium valproate in adults with newly diagnosed epilepsy. Epilepsy Research 1997;26(3):451-60.
4. Castillo 2000 Castillo S, Schmidt DB, White S. Oxcarbazepine add-on for drugresistant partial epilepsy. Cochrane Database of Systematic Reviews 2000, Issue 3.[Art. No.: CD002028. DOI: 10.1002/14651858.CD002028]
5. Cockerell 1995 Cockerell OC, Johnson AL, Sander JW, Hart YM, Shorvon SD. Remission of epilepsy: results from the National General Practice Study of Epilepsy. Lancet 1995;346(8968):140-4.
6. Commission 1998 ILAE commission on antiepileptic drugs. Considerations on designing clinical trials to evaluate the place of new antiepileptic drugs in the treatment of newly diagnosed and chronic patients with epilepsy. Epilepsia 1998;39(7):799-803.
7. EBCTCG 1990 Early Breast Cancer Trialists' Collaborative Group. Treatment of early breast cancer, worldwide evidence, 1985-90. Oxford: Oxford University Press, 1990.
8. Gladstone 1992 Gladstone DJ, Bologa M, Maguire C, Pastuszak A, Koren G. Course of pregnancy and fetal outcome following maternal exposure to carbamazepine and phenytoin: a prospective study. Reproductive Toxicology 1992;6(3):257-61.
9. Higgins 2005 Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 [updated May 2005]; Appendix 5b. www.cochrane.org/resources/handbook/hbook.htm (accessed 19 December 2005).
10. ILAE 1981 Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia 1981;22(4):489-501.
11. ILAE 1989 Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 1989;30(4):389-99.
12. Mattson 1985 Mattson RH, Cramer JA, Collins JF, Smith DB, Delgado-Escueta AV, Browne TR, et al.Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures. New England Journal of Medicine 1985;313(3):145-51.
13. Nulman 1997 Nulman I, Scolnik D, Chitayat D, Farkas LD, Koren G. Findings in children exposed in utero to phenytoin and carbamazepine monotherapy: independent effects of epilepsy and medications. American Journal of Medical Genetics 1997;68(1):18-24.
14. Parmar 1998 Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Statistics in Medicine 1998;17(24):2815-34.
15. Pohlmann 2005 Pohlmann H. Personal communication 23 September 2005.
16. SANAD A Study of Standard and New Antiepileptic Drugs. http://www.liv.ac.uk/neuroscience/.
17. Tennis 1997 Tennis P, Stern RS. Risk of serious cutaneous disorders after initiation of use of phenytoin, carbamazepine, or sodium valproate: a record linkage study. Neurology 1997;49(2):542-6.
18. Wallace 1997 Wallace H, Shorvon SD, Hopkins A, O'Donoghue M. Guidelines for the clinical management of adults with poorly controlled epilepsy. National Society of Epilepsy guidelines. London: Royal College of Physicians, 1997.
19. Wilder 1995 Wilder BJ. Phenytoin: clinical use. Antiepileptic drugs. 4th Edition. New York: Raven Press, 1995:339-44.
20. Williamson 2002 Williamson PR, Tudur Smith C, Hutton JL, Marson AG. Aggregate data meta-analysis with time-to-event outcomes. Statistics in Medicine 2002;21(22):3337-51.